Model-Informed Development of a Cost-Saving Dosing Regimen for Sacituzumab Govitecan
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Model-Informed Development of a Cost-Saving Dosing Regimen for Sacituzumab Govitecan ; day:18 ; month:6 ; year:2024 ; pages:1-8
Targeted oncology ; (18.6.2024), 1-8
- Urheber
-
Moes, Dirk J. A. R.
Hendrikx, Jeroen J. M. A.
Guchelaar, Henk-Jan
Mathijssen, Ron H. J.
Bakker, J. L.
Dezentjé, Vincent O.
Rouw, Nikki de
Erp, Nielka P. van
Smit, Egbert F.
den Heuvel, Michel M. van
Munnink, Thijs H. Oude
Kats, Maartje van
Croes, Sander
Kroep, Judith R.
Zwaveling, Juliette
Heine, Rob ter
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s11523-024-01075-8
- URN
-
urn:nbn:de:101:1-2409110944093.185266711229
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:37 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Moes, Dirk J. A. R.
- Hendrikx, Jeroen J. M. A.
- Guchelaar, Henk-Jan
- Mathijssen, Ron H. J.
- Bakker, J. L.
- Dezentjé, Vincent O.
- Rouw, Nikki de
- Erp, Nielka P. van
- Smit, Egbert F.
- den Heuvel, Michel M. van
- Munnink, Thijs H. Oude
- Kats, Maartje van
- Croes, Sander
- Kroep, Judith R.
- Zwaveling, Juliette
- Heine, Rob ter
- SpringerLink (Online service)
Ähnliche Objekte (12)
Personalized Tuberculosis Treatment Through Model-Informed Dosing of Rifampicin
Pembrolizumab Weight-Based Dosing: Conviction and Lacunae in Adopting a Cost-Saving Approach—A Survey Report
Personalized Antifungal Therapy Through Model-Informed Precision Dosing of Posaconazole
A Systematic Evaluation of Cost-Saving Dosing Regimens for Therapeutic Antibodies and Antibody-Drug Conjugates for the Treatment of Lung Cancer
Model-Informed Precision Dosing of Everolimus: External Validation in Adult Renal Transplant Recipients
Bayesian data assimilation and reinforcement learning for model-informed precision dosing in oncology
Minimally important difference in cost savings: Is it possible to identify an MID for cost savings?
Cooperation among farmers for cost saving machinery
Horizontal mergers, cost savings, and network effects
Potential cost savings with terrestrial rabies control
Novel approaches to improve model-informed precision dosing in haemophilia A and infectious diseases
Effect of blood protein concentrations on drug-dosing regimes: practical guidance
Personalized Tuberculosis Treatment Through Model-Informed Dosing of Rifampicin
Pembrolizumab Weight-Based Dosing: Conviction and Lacunae in Adopting a Cost-Saving Approach—A Survey Report
Personalized Antifungal Therapy Through Model-Informed Precision Dosing of Posaconazole
A Systematic Evaluation of Cost-Saving Dosing Regimens for Therapeutic Antibodies and Antibody-Drug Conjugates for the Treatment of Lung Cancer
Model-Informed Precision Dosing of Everolimus: External Validation in Adult Renal Transplant Recipients
Bayesian data assimilation and reinforcement learning for model-informed precision dosing in oncology
Minimally important difference in cost savings: Is it possible to identify an MID for cost savings?
Cooperation among farmers for cost saving machinery
Horizontal mergers, cost savings, and network effects
Potential cost savings with terrestrial rabies control
Novel approaches to improve model-informed precision dosing in haemophilia A and infectious diseases
Effect of blood protein concentrations on drug-dosing regimes: practical guidance
Personalized Tuberculosis Treatment Through Model-Informed Dosing of Rifampicin
Pembrolizumab Weight-Based Dosing: Conviction and Lacunae in Adopting a Cost-Saving Approach—A Survey Report
Personalized Antifungal Therapy Through Model-Informed Precision Dosing of Posaconazole
A Systematic Evaluation of Cost-Saving Dosing Regimens for Therapeutic Antibodies and Antibody-Drug Conjugates for the Treatment of Lung Cancer
Model-Informed Precision Dosing of Everolimus: External Validation in Adult Renal Transplant Recipients
Bayesian data assimilation and reinforcement learning for model-informed precision dosing in oncology
Minimally important difference in cost savings: Is it possible to identify an MID for cost savings?
Cooperation among farmers for cost saving machinery
Horizontal mergers, cost savings, and network effects
Potential cost savings with terrestrial rabies control
Novel approaches to improve model-informed precision dosing in haemophilia A and infectious diseases